GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Cash Flow from Discontinued Operations

Oncodesign Precision Medicine (XPAR:ALOPM) Cash Flow from Discontinued Operations

: €0.00 Mil (TTM As of Jun. 2022)
View and export this data going back to 2022. Start your Free Trial

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Oncodesign Precision Medicine's cash flow from discontinued operations for the six months ended in Jun. 2022 was €0.00 Mil. It means Oncodesign Precision Medicine received €0.00 Mil from the sale of part of business quarterly. Oncodesign Precision Medicine's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Jun. 2022 was €0.00 Mil.

Oncodesign Precision Medicine Cash Flow from Discontinued Operations Historical Data

The historical data trend for Oncodesign Precision Medicine's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21
Cash Flow from Discontinued Operations
- -

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22
Cash Flow from Discontinued Operations - - -

Oncodesign Precision Medicine Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncodesign Precision Medicine Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine (XPAR:ALOPM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
Traded in Other Exchanges
N/A
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Website
https://www.opm.oncodesign.com
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (XPAR:ALOPM) Headlines

No Headlines